Infections
| . | Total, n (%) . |
|---|---|
| No. of patients who received transplant | 27 |
| No. of patients with infections | 18 (67) |
| No. of patients with infection reports | |
| 1 | 4 (15) |
| 2 | 9 (33) |
| 3 | 3 (11) |
| 4 | 2 (7) |
| 5 | 0 |
| ≥6 | 0 |
| Total infection events | 39 |
| Maximum severity based on the patient | |
| None | 0 |
| Grade 2 | 37 |
| Grade 5 | 2 |
| Infection type (no. of patients) | |
| Bacterial | 11 |
| Viral | 20 |
| Fungal | 4 |
| Incidence of CMV infection (no. of patients) | 11 |
| CMV infection requiring therapy | 6 |
| Incidence of EBV infection (no. of patients) | 2 |
| EBV infection requiring therapy | 1 |
| Incidence of PTLD (no. of patients) | 1 |
| . | Total, n (%) . |
|---|---|
| No. of patients who received transplant | 27 |
| No. of patients with infections | 18 (67) |
| No. of patients with infection reports | |
| 1 | 4 (15) |
| 2 | 9 (33) |
| 3 | 3 (11) |
| 4 | 2 (7) |
| 5 | 0 |
| ≥6 | 0 |
| Total infection events | 39 |
| Maximum severity based on the patient | |
| None | 0 |
| Grade 2 | 37 |
| Grade 5 | 2 |
| Infection type (no. of patients) | |
| Bacterial | 11 |
| Viral | 20 |
| Fungal | 4 |
| Incidence of CMV infection (no. of patients) | 11 |
| CMV infection requiring therapy | 6 |
| Incidence of EBV infection (no. of patients) | 2 |
| EBV infection requiring therapy | 1 |
| Incidence of PTLD (no. of patients) | 1 |
PTLD, posttransplant lymphoproliferative disease